课题基金 / 基金详情

Immunoregulatory nanovaccines: Optimization of physical, chemical, pharmacokinetic and immunological properties for bench-to-bedside translation

Immunoregulatory nanovaccines: Optimization of physical, chemical, pharmacokinetic and immunological properties for bench-to-bedside translation
免疫调节纳米疫苗:优化物理、化学、药代动力学和免疫学特性,实现实验室到临床的转化
批准号:
397565-2011
负责人:
Santamaria, Pere
金额:
$7.04万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Health Research Projects
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-01-01 至 2012-12-31

项目摘要

项目成果

Santamaria, Pere的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The current proposal is founded on the discovery of a new paradigm in the treatment of type 1 diabetes (caused
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunoregulatory nanovaccines: Optimization of physical, chemical, pharmacokinetic and immunological properties for bench-to-bedside translation
  • 批准号:
    397565-2011
  • 项目类别:
    Collaborative Health Research Projects
  • 资助金额:
    $7.04万
  • 财政年份:
    2013
  • 负责人:
    Santamaria, Pere
  • 依托单位:
Immunoregulatory nanovaccines: Optimization of physical, chemical, pharmacokinetic and immunological properties for bench-to-bedside translation
  • 批准号:
    397565-2011
  • 项目类别:
    Collaborative Health Research Projects
  • 资助金额:
    $7.04万
  • 财政年份:
    2012
  • 负责人:
    Santamaria, Pere
  • 依托单位:
Mechanisms underlying the antigenic promiscuity of a pathogenic autoreactive CD8+T-cell specificity
  • 批准号:
    155725-2007
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.74万
  • 财政年份:
    2011
  • 负责人:
    Santamaria, Pere
  • 依托单位:
Mechanisms underlying the antigenic promiscuity of a pathogenic autoreactive CD8+T-cell specificity
  • 批准号:
    155725-2007
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.74万
  • 财政年份:
    2010
  • 负责人:
    Santamaria, Pere
  • 依托单位:
海外基金